Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
02/2002
02/21/2002WO2002013827A1 Process for the preparation of dinapsoline
02/21/2002WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity
02/21/2002WO2002013802A2 Method of treating estrogen receptor positive carcinoma
02/21/2002WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors
02/21/2002WO2001032631A3 Heterocyclic cytotoxic agents
02/21/2002US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/21/2002US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration
02/21/2002US20020022616 Azepino[4,5-b]pyrano[3,2-e]indoles
02/21/2002US20020022575 Dialkyl-halogenophenyl-substituted ketoenols
02/21/2002CA2418273A1 Urea compounds and methods of uses
02/21/2002CA2417807A1 Process for the preparation of dinapsoline
02/20/2002CN1336929A Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
02/20/2002CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands
02/20/2002CN1336375A Spiro-and dicyclic diazine and carbozine oxazolidohne compound
02/19/2002US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
02/19/2002US6348595 Perylene-3,4,9,10-tetracarboximide is hydroxymethylated by reaction with formaldehyde to form bis(hydroxymethyl) perylene-3,4,9,10-tetracarboximide; one pot process
02/19/2002US6348467 Antitumor agent from animal extracts
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012195A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
02/14/2002WO2002012188A2 Indole compounds useful for the treatment of cancer
02/14/2002WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/14/2002WO2001051479A3 Tricyclic compounds with antiviral activity
02/14/2002US20020019531 Indoles
02/14/2002US20020019412 Antidiabetic agents
02/14/2002US20020019397 Heterocycle carboxamides as antiviral agents
02/14/2002US20020019390 Imidazole and imidazoline derivatives and uses thereof
02/14/2002US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example
02/14/2002US20020019388 (cis)-6-(3-pyridinyl)-3,6-diazabicyclo(3.2.0) heptane for example; Alzheimer's disease, Parkinson's disease, attention deficit hyperactivity disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, and schizophrenia
02/14/2002CA2419060A1 Indole compounds useful for the treatment of cancer
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002CA2417816A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
02/13/2002EP1178982A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
02/13/2002EP1178973A2 Novel compounds, their use and preparation
02/13/2002EP1100799B1 Preparation of camptothecin and nothapodytine derivatives
02/13/2002EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
02/13/2002EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
02/13/2002EP0869942B1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
02/13/2002EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids
02/13/2002EP0819112B1 Oxidative process for preparing narwedine derivatives
02/13/2002CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use
02/13/2002CN1335836A Tricyclic pyrazole derivatives
02/13/2002CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent
02/13/2002CN1335062A Fungicide composition
02/12/2002US6346621 Indole or quinoline compounds substituted with amino compounds on nitrogen
02/12/2002US6346618 Optical resolution of narwedine-type compounds
02/12/2002US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives
02/12/2002US6346536 Benzopyranoisoquinolone derivatives; neurodegenerative and brain disorders; reperfusion injuries; antiischemic agents
02/12/2002CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same
02/07/2002WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
02/07/2002WO2002010140A2 Imidazolyl derivatives
02/07/2002WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
02/07/2002WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
02/07/2002US20020016460 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer
02/07/2002US20020016355 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline
02/07/2002US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
02/07/2002US20020016337 Heterocyclic analgesic compounds and methods of use thereof
02/07/2002DE10036818A1 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten New N-triazolylmethyl piperazine derivatives as neurokinin receptor antagonists
02/07/2002CA2417204A1 Imidazolyl derivatives
02/07/2002CA2385908A1 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
02/06/2002EP1177191A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
02/06/2002EP0771198B1 Dihydro-2,3-benzodiazepine derivatives
02/06/2002CN1334812A Piperazine derivatives
02/06/2002CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists
02/06/2002CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof
01/2002
01/31/2002WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
01/31/2002WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
01/31/2002WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics
01/31/2002US20020013460 Condensed pyridine compound
01/31/2002US20020013354 p38 map kinase inhibitors
01/31/2002US20020013336 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
01/31/2002US20020013334 HMG-CoA reductase inhibitors and method
01/31/2002US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers
01/31/2002US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester
01/31/2002US20020012683 Cosmetic composition comprising at least one ingredient chosen from compounds of formula (1) and salts thereof, use thereof as colouring agent, and novel compounds of formulae (IIa), (IIIa), (IVa), (Va), and (VIa), and salts thereof
01/31/2002DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases
01/31/2002DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use
01/31/2002DE10034625A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis
01/31/2002DE10034624A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis facto-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, cardiac infraction and psoriasis
01/31/2002CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
01/30/2002EP1176144A1 N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists
01/30/2002EP1176140A1 Amide compounds and medicinal use thereof
01/30/2002EP1175398A1 Indoline derivatives as progesterone antagonists
01/30/2002CN1333774A Substituted benzofuranodindoles and indenoindoles as novel potassium channel openers
01/30/2002CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors
01/30/2002CN1333764A Benzofuran derivatives, process for the preparation of the same and uses thereof
01/30/2002CN1333758A Substituted bicyclic derivatives useful as anticancer agents
01/30/2002CN1333753A Quinolinecarboxamides as antiviral agents
01/29/2002US6342606 Method for producing pyridine derivatives
01/29/2002US6342601 Treating allograft rejection, rheumatoid arthritis
01/29/2002US6342516 Phenylazole compounds, process for producing the same and drugs for hyperlipemia
01/29/2002US6342459 Photochromic naphthopyrans
01/24/2002WO2002006361A2 Novel photochromic polymers and methods of synthesizing same
01/24/2002WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors
01/24/2002WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/24/2002WO2002005860A1 Radioligand and binding assay
01/24/2002WO2002005819A1 Compounds and methods
01/24/2002WO2001058875A3 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
01/24/2002WO2000053614A8 Method for producing glyco-conjugates of 20(s)-camptothecin
01/24/2002US20020010206 Treating cyclooxygenase-2 mediated disorders.